WebDisclosure WebDisclosure
Basculer en Français
10272 Companies
212515 Keywords
142327 Articles
112538 Press releases
Headlines Articles Press releases Ferrosa Therapeutics AG Remove
  1. Home
  2. Companies
  3. Ferrosa Therapeutics AG
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/23/2026 at 14:10, 2 hours 31 minutes ago

    Ferrosa Therapeutics Secures Seed Financing for Innovative Anemia Treatment

    Chronic Diseases Seed Financing Bispecific Antibody Ferrosa Therapeutics Anemia Treatment
  • BRIEF

    published on 04/23/2026 at 14:10, 2 hours 31 minutes ago

    Ferrosa Therapeutics obtient un financement de démarrage pour un traitement innovant contre l'anémie

    Maladies Chroniques Financement De Démarrage Anticorps Bispécifique Ferrosa Thérapeutique Traitement De L'anémie
  • PRESS RELEASE

    published on 04/23/2026 at 14:05, 2 hours 36 minutes ago

    FERROSA THERAPEUTICS ANNOUNCES SEED FINANCING TO ADVANCE A FIRST-IN-CLASS BISPECIFIC ANTIBODY PROGRAM FOR ANEMIA OF INFLAMMATION

    Ferrosa Therapeutics announces USD 3.5 Million seed financing to advance first-in-class bispecific antibody program for anemia of inflammation. Company targets chronic kidney disease, autoimmune disease, and cancer
    Seed Financing Bispecific Antibody Ferrosa Therapeutics Anemia Of Inflammation Forty51 Ventures
    Logo of Ferrosa Therapeutics AG
Accesswire
  • Published on 04/23/2026 at 16:20, 21 minutes ago

    CORRECTION FROM SOURCE: Avino Announces Q1 2026 Production Results

  • Published on 04/23/2026 at 15:00, 1 hour 41 minutes ago

    critical elements annonce les résultats de l'assemblée annuelle des actionnaires

  • Published on 04/23/2026 at 15:00, 1 hour 41 minutes ago

    Critical Elements Announces the Results from The Annual Meeting of Shareholders

  • Published on 04/23/2026 at 14:30, 2 hours 11 minutes ago

    Klondike Gold Engages Fundamental Research Corp. for Analyst Coverage

  • Published on 04/23/2026 at 14:30, 2 hours 11 minutes ago

    Hillcrest Energy Technologies Finalizes A-Sample Design of ZVS PCS1000 Sidecar Power Unit for Next-Generation AI Data Centers

View all ACCESSWIRE
EQS Group
  • Published on 04/23/2026 at 16:32, 9 minutes ago

    E.ON Annual General Meeting again approves higher dividend

  • Published on 04/23/2026 at 16:06, 34 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc

  • Published on 04/23/2026 at 16:06, 35 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Senior plc

  • Published on 04/23/2026 at 16:05, 36 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Schroders plc

  • Published on 04/23/2026 at 16:05, 36 minutes ago

    Brandwatch Expands APAC Data Coverage to Strengthen Global Insight for Marketers

View all EQS
Les Echos
  • Published on 04/23/2026 at 15:39, 1 hour 1 minute ago

    DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

  • Published on 04/23/2026 at 15:39, 1 hour 1 minute ago

    DECLARATION DU NOMBRE D’ACTIONS ET DE DROITS DE VOTE

  • Published on 04/23/2026 at 15:00, 1 hour 41 minutes ago

    STEF : Descriptif du programme de rachat d'actions

  • Published on 04/23/2026 at 14:30, 2 hours 11 minutes ago

    KURMA PARTNERS, AN EURAZEO GROUP COMPANY, CLOSES €215 MILLION BIOFUND IV

  • Published on 04/23/2026 at 14:30, 2 hours 11 minutes ago

    KURMA PARTNERS, MEMBRE DU GROUPE EURAZEO, ANNONCE LE CLOSING FINAL DE SON NOUVEAU FONDS BIOFUND IV A 215 MILLIONS D’EUROS

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy